Form EFFECT Esperion Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2026 |
| Accession Number: | 0001104659-26-083007 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AM Best Comments on Credit Ratings of Universal Shield Insurance Group Subsidiaries Following Announced Transaction with Tiptree Inc.
- Oliver Bell Group Wins Michigan Supreme Court Case, Restoring Rights for Families in Medical Malpractice Wrongful Death Cases
- Digital Lifestyle Expert Mario Armstrong and News Media Group, Inc. Showcase the Ultimate "Cool for School" Tech and Learning Essentials on a Nationwide Satellite Media Tour
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
